Home

Pacira BioSciences, Inc.

CIK 1396814 · last filed 2019-11-13

Pacira BioSciences, Inc. is a corporate insider who has filed 1 SEC Form 4 insider transactions across 1 company since 2019. The most recent filing, for TELA, was dated Nov 13, 2019. Current disclosed insider exposure totals $635.9K across reported positions. The firm reports its address in Brisbane, CA. 71 SEC filings were submitted jointly with DAVID M STACK.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$635.9K

Companies

1

Total Filings

1

Lifetime Open-Market Net

$0

Filer Profile

Reported Address
2000 SIERRA POINT PARKWAY
SUITE 900
BRISBANE, CA 94005
Phone
(650) 242-8052
State of Incorporation
DE
Formerly Known As
Pacira Pharmaceuticals, Inc. (2010–2019)
PACIRA INC (2008–2008)
Blue Acquisition Corp (2007–2007)
Related Filers
DAVID M STACK — 71 joint filings, latest 2023-06-16
LAUREN RIKER — 63 joint filings, latest 2026-06-12
KRISTEN WILLIAMS — 45 joint filings, latest 2026-06-05
Andreas Wicki — 44 joint filings, latest 2021-03-16
PAUL J HASTINGS — 35 joint filings, latest 2024-06-13
JONATHAN SLONIN — 33 joint filings, latest 2026-08-18
GARY W PACE — 29 joint filings, latest 2024-03-08
Laura Brege — 26 joint filings, latest 2026-06-12
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TELA Director 774,056 $0.82 $635.9K $0 1 2019-11-13

Recent Filings

1 filing
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2019-11-13 TELA Conv (C) +1,160,714 $0 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.